{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:52:14Z","timestamp":1761519134484,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer (US)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11102-015-0688-8","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T12:12:03Z","timestamp":1445688723000},"page":"65-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH\/IGF kinetics in adults suspected of GH deficiency"],"prefix":"10.1007","volume":"19","author":[{"given":"Kevin C. J.","family":"Yuen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Frystyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon A.","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"688_CR1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4158\/EP.15.6.580","volume":"15","author":"DM Cook","year":"2009","unstructured":"Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML, American Association of Clinical E (2009) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients\u20142009 update. Endocr Pract 15:580\u2013586","journal-title":"Endocr Pract"},{"key":"688_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"KK Ho","year":"2007","unstructured":"Ho KK, Participants GHDCW (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695\u2013700","journal-title":"Eur J Endocrinol"},{"key":"688_CR3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine S (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1994.tb03793.x","volume":"41","author":"SL Jones","year":"1994","unstructured":"Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A (1994) An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41:123\u2013128","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2007-979000","volume":"29","author":"P Vestergaard","year":"1997","unstructured":"Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P (1997) Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res 29:106\u2013110","journal-title":"Horm Metab Res"},{"key":"688_CR6","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","volume":"87","author":"BM Biller","year":"2002","unstructured":"Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067\u20132079","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1530\/EJE-07-0384","volume":"157","author":"G Corneli","year":"2007","unstructured":"Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V, Baldelli R, Rovere S, Schneider HJ, Gargantini L, Gastaldi R, Ghizzoni L, Valle D, Salerno M, Colao A, Bona G, Ghigo E, Maghnie M, Aimaretti G (2007) Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 157:701\u2013708","journal-title":"Eur J Endocrinol"},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1210\/jc.2009-0299","volume":"94","author":"KC Yuen","year":"2009","unstructured":"Yuen KC, Biller BM, Molitch ME, Cook DM (2009) Clinical review: is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab 94:2702\u20132707","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1530\/EJE-09-0824","volume":"162","author":"C Berg","year":"2010","unstructured":"Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S (2010) Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol 162:477\u2013482","journal-title":"Eur J Endocrinol"},{"key":"688_CR10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/BF03345251","volume":"26","author":"FL Conceicao","year":"2003","unstructured":"Conceicao FL, Da Costa e Silva A, Leal Costa AJ, Vaisman M (2003) Glucagon stimulation test for the diagnosis of GH deficiency in adults. J Endocrinol Invest 26:1065\u20131070","journal-title":"J Endocrinol Invest"},{"key":"688_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2265.2002.01472.x","volume":"56","author":"JM Gomez","year":"2002","unstructured":"Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera-Pombo JL, Vilardell E, Duran A, Mesa J, Faure E, Sanmarti A (2002) Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clin Endocrinol (Oxf) 56:329\u2013334","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR12","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1210\/jc.2009-2697","volume":"95","author":"N Iorgi di","year":"2010","unstructured":"di Iorgi N, Napoli F, Allegri A, Secco A, Calandra E, Calcagno A, Frassinetti C, Ghezzi M, Ambrosini L, Parodi S, Gastaldi R, Loche S, Maghnie M (2010) The accuracy of the glucagon test compared to the insulin tolerance test in the diagnosis of adrenal insufficiency in young children with growth hormone deficiency. J Clin Endocrinol Metab 95:2132\u20132139","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR13","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1210\/jc.2009-0779","volume":"94","author":"A Secco","year":"2009","unstructured":"Secco A, di Iorgi N, Napoli F, Calandra E, Ghezzi M, Frassinetti C, Parodi S, Casini MR, Lorini R, Loche S, Maghnie M (2009) The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. J Clin Endocrinol Metab 94:4251\u20134257","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jcem-73-5-1081","volume":"73","author":"A Iranmanesh","year":"1991","unstructured":"Iranmanesh A, Lizzarralde G, Veldhuis JD (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081\u20131088","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","volume":"37","author":"RC Cuneo","year":"1992","unstructured":"Cuneo RC, Salomon F, McGauley GA, Sonksen PH (1992) The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 37:387\u2013397","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11102-010-0270-3","volume":"14","author":"Z Karaca","year":"2011","unstructured":"Karaca Z, Lale A, Tanriverdi F, Kula M, Unluhizarci K, Kelestimur F (2011) The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary 14:134\u2013140","journal-title":"Pituitary"},{"key":"688_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/cen.12528","volume":"82","author":"Y Simsek","year":"2015","unstructured":"Simsek Y, Karaca Z, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F (2015) A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders. Clin Endocrinol (Oxf) 82:45\u201352","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/eje.0.1430099","volume":"143","author":"E Arvat","year":"2000","unstructured":"Arvat E, Maccagno B, Ramunni J, Maccario M, Giordano R, Broglio F, Camanni F, Ghigo E (2000) Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur J Endocrinol 143:99\u2013104","journal-title":"Eur J Endocrinol"},{"key":"688_CR19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11102-012-0407-7","volume":"16","author":"KC Yuen","year":"2013","unstructured":"Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, Corazzini V, Spiller K, Gordon MB, Salvatori R, Cook DM (2013) Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary 16:220\u2013230","journal-title":"Pituitary"},{"key":"688_CR20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","volume":"358","author":"AJ Lely van der","year":"2001","unstructured":"van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358:1754\u20131759","journal-title":"Lancet"},{"key":"688_CR21","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1210\/jc.2001-011885","volume":"87","author":"JD Veldhuis","year":"2002","unstructured":"Veldhuis JD, Bidlingmaier M, Anderson SM, Evans WS, Wu Z, Strasburger CJ (2002) Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men. J Clin Endocrinol Metab 87:5737\u20135745","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR22","first-page":"3304","volume":"86","author":"JD Veldhuis","year":"2001","unstructured":"Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strasburger CJ (2001) Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal\/nonpulsatile GH release in healthy women and men. J Clin Endocrinol Metab 86:3304\u20133310","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1365-2265.2007.03132.x","volume":"68","author":"G Radetti","year":"2008","unstructured":"Radetti G, Wu Z, Elsedfy HH, El Kholy M, Bozzola M, Strasburger CJ (2008) Pegvisomant-primed GH stimulation test. Clin Endocrinol (Oxf) 68:951\u2013956","journal-title":"Pegvisomant-primed GH stimulation test. Clin Endocrinol (Oxf)"},{"key":"688_CR24","first-page":"2098","volume":"84","author":"MO Thorner","year":"1999","unstructured":"Thorner MO, Strasburger CJ, Wu Z, Straume M, Bidlingmaier M, Pezzoli SS, Zib K, Scarlett JC, Bennett WF (1999) Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH. J Clin Endocrinol Metab 84:2098\u20132103","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR25","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2012.188128","volume":"58","author":"J Manolopoulou","year":"2012","unstructured":"Manolopoulou J, Alami Y, Petersenn S, Schopohl J, Wu Z, Strasburger CJ, Bidlingmaier M (2012) Automated 22-kD growth hormone-specific assay without interference from Pegvisomant. Clin Chem 58:1446\u20131456","journal-title":"Clin Chem"},{"key":"688_CR26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1210\/jc.2013-3060","volume":"99","author":"N Friedrich","year":"2014","unstructured":"Friedrich N, Wolthers OD, Arafat AM, Emeny RT, Spranger J, Roswall J, Kratzsch J, Grabe HJ, Hubener C, Pfeiffer AF, Doring A, Bielohuby M, Dahlgren J, Frystyk J, Wallaschofski H, Bidlingmaier M (2014) Age- and sex-specific reference intervals across life span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 ratio measured by new automated chemiluminescence assays. J Clin Endocrinol Metab 99:1675\u20131686","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1373\/clinchem.2010.150631","volume":"57","author":"DR Clemmons","year":"2011","unstructured":"Clemmons DR (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 57:555\u2013559","journal-title":"Clin Chem"},{"key":"688_CR28","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J, Korner A, Obermayer-Pietsch B, Hubener C, Dahlgren J, Frystyk J, Pfeiffer AF, Doering A, Bielohuby M, Wallaschofski H, Arafat AM (2014) Reference intervals for insulin-like growth factor-I (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab 99:1712\u20131721","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR29","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","volume":"284","author":"JW Chen","year":"2003","unstructured":"Chen JW, Ledet T, Orskov H, Jessen N, Lund S, Whittaker J, De Meyts P, Larsen MB, Christiansen JS, Frystyk J (2003) A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 284:E1149\u2013E1155","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"688_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2369-14-80","volume":"14","author":"M Reinhard","year":"2013","unstructured":"Reinhard M, Frystyk J, Jespersen B, Bjerre M, Christiansen JS, Flyvbjerg A, Ivarsen P (2013) Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study. BMC Nephrol 14:80","journal-title":"BMC Nephrol"},{"key":"688_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.domaniend.2011.11.005","volume":"43","author":"J Frystyk","year":"2012","unstructured":"Frystyk J (2012) Quantification of the GH\/IGF-axis components: lessons from human studies. Domest Anim Endocrinol 43:186\u2013197","journal-title":"Domest Anim Endocrinol"},{"key":"688_CR32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1210\/jc.2014-3521","volume":"100","author":"JS Sorensen","year":"2015","unstructured":"Sorensen JS, Birkebaek NH, Bjerre M, Pociot F, Kristensen K, Hoejberg AS, Frystyk J, Danish Society for Diabetes in C, Adolescence (2015) Residual beta-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes. J Clin Endocrinol Metab 100:1053\u20131061","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR33","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1210\/jc.2010-0538","volume":"95","author":"JD Veldhuis","year":"2010","unstructured":"Veldhuis JD, Bidlingmaier M, Bailey J, Erickson D, Sandroni P (2010) A pegylated growth hormone receptor antagonist, pegvisomant, does not enter the brain in humans. J Clin Endocrinol Metab 95:3844\u20133847","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/eje.0.1420347","volume":"142","author":"G Aimaretti","year":"2000","unstructured":"Aimaretti G, Baffoni C, DiVito L, Bellone S, Grottoli S, Maccario M, Arvat E, Camanni F, Ghigo E (2000) Comparisons among old and new provocative tests of GH secretion in 178 normal adults. Eur J Endocrinol 142:347\u2013352","journal-title":"Eur J Endocrinol"},{"key":"688_CR35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","volume":"45","author":"A Rahim","year":"1996","unstructured":"Rahim A, Toogood AA, Shalet SM (1996) The assessment of growth hormone status in normal young adult males using a variety of provocative agents. Clin Endocrinol (Oxf) 45:557\u2013562","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR36","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1210\/jc.2014-2830","volume":"99","author":"LE Dichtel","year":"2014","unstructured":"Dichtel LE, Yuen KC, Bredella MA, Gerweck AV, Russell BM, Riccio AD, Gurel MH, Sluss PM, Biller BM, Miller KK (2014) Overweight\/obese adults with pituitary disorders require lower peak growth hormone cutoff values on glucagon stimulation testing to avoid overdiagnosis of growth hormone deficiency. J Clin Endocrinol Metab 99:4712\u20134719","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ecl.2014.10.003","volume":"44","author":"RK Junnila","year":"2015","unstructured":"Junnila RK, Strasburger CJ, Bidlingmaier M (2015) Pitfalls of insulin-like growth factor-i and growth hormone assays. Endocrinol Metab Clin North Am 44:27\u201334","journal-title":"Endocrinol Metab Clin North Am"},{"key":"688_CR38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2265.2008.03481.x","volume":"70","author":"CA Berg","year":"2009","unstructured":"Berg CA, Pokrajac A, Bidlingmaier M, Strasburger CJ, Shalet SM, Trainer PJ (2009) Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD). Clin Endocrinol (Oxf) 70:439\u2013445","journal-title":"Clin Endocrinol (Oxf)"},{"key":"688_CR39","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/MCB.01011-12","volume":"32","author":"X Shen","year":"2012","unstructured":"Shen X, Xi G, Maile LA, Wai C, Rosen CJ, Clemmons DR (2012) Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling. Mol Cell Biol 32:4116\u20134130","journal-title":"Mol Cell Biol"},{"key":"688_CR40","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1210\/jc.2008-2086","volume":"94","author":"CE Higham","year":"2009","unstructured":"Higham CE, Rowles S, Russell-Jones D, Umpleby AM, Trainer PJ (2009) Pegvisomant improves insulin sensitivity and reduces overnight free fatty acid concentrations in patients with acromegaly. J Clin Endocrinol Metab 94:2459\u20132463","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2013-3264","volume":"99","author":"A Thankamony","year":"2014","unstructured":"Thankamony A, Tossavainen PH, Sleigh A, Acerini C, Elleri D, Dalton RN, Jackson NC, Umpleby AM, Williams RM, Dunger DB (2014) Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. J Clin Endocrinol Metab 99:639\u2013647","journal-title":"J Clin Endocrinol Metab"},{"key":"688_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2005.11.001","volume":"16","author":"S Fisker","year":"2006","unstructured":"Fisker S (2006) Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects. Growth Horm IGF Res 16:1\u201328","journal-title":"Growth Horm IGF Res"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0688-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-015-0688-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0688-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:08:24Z","timestamp":1559354904000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-015-0688-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s11102-015-0688-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}